Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (91-100 of 447) with videos related to

Pageof 45
Sort By:
BMC Cancer|December 8, 2006
Gene expression patterns associated with p53 status in breast cancerMelissa A Troester, Jason I Herschkowitz, Daniel S Oh, et al.
The Oncologist|August 22, 2014
Age-specific changes in intrinsic breast cancer subtypes: a focus on older womenEmily O Jenkins, Allison M Deal, Carey K Anders, et al.
Cancer Discovery|March 5, 2015
Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancerMei Zhang, Anna Tsimelzon, Chi-Hsuan Chang, et al.
Breast Cancer Research and Treatment|June 15, 2011
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapseJ Chuck Harrell, Aleix Prat, Joel S Parker, et al.
Journal of the National Cancer Institute|August 21, 2014
Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancerAleix Prat, Lisa A Carey, Barbara Adamo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.
Genes & Cancer|March 15, 2013
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer SubtypesBrittni A Smith, Dawne N Shelton, Collin Kieffer, et al.
Nucleic Acids Research|March 13, 2018
The association between copy number aberration, DNA methylation and gene expression in tumor samplesWei Sun, Paul Bunn, Chong Jin, et al.
Cancer Treatment Reviews|May 16, 2018
Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancerJuan Miguel Cejalvo, Tomás Pascual, Aranzazu Fernández-Martínez, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
Pageof 45

Showing results (91-100 of 447) with videos related to

Sort By:
Pageof 45
BMC Cancer|December 8, 2006
Gene expression patterns associated with p53 status in breast cancerMelissa A Troester, Jason I Herschkowitz, Daniel S Oh, et al.
The Oncologist|August 22, 2014
Age-specific changes in intrinsic breast cancer subtypes: a focus on older womenEmily O Jenkins, Allison M Deal, Carey K Anders, et al.
Cancer Discovery|March 5, 2015
Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancerMei Zhang, Anna Tsimelzon, Chi-Hsuan Chang, et al.
Breast Cancer Research and Treatment|June 15, 2011
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapseJ Chuck Harrell, Aleix Prat, Joel S Parker, et al.
Journal of the National Cancer Institute|August 21, 2014
Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancerAleix Prat, Lisa A Carey, Barbara Adamo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.
Genes & Cancer|March 15, 2013
Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer SubtypesBrittni A Smith, Dawne N Shelton, Collin Kieffer, et al.
Nucleic Acids Research|March 13, 2018
The association between copy number aberration, DNA methylation and gene expression in tumor samplesWei Sun, Paul Bunn, Chong Jin, et al.
Cancer Treatment Reviews|May 16, 2018
Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancerJuan Miguel Cejalvo, Tomás Pascual, Aranzazu Fernández-Martínez, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
Pageof 45